KAM
CLVS
Kazazian Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $1.31M | Buy |
332,635
+255,853
| +333% | +$1.01M | 1.76% | 18 |
|
|
2019
Q2 | $1.14M | Sell |
76,782
-20,038
| -21% | -$298K | 1.35% | 24 |
|
|
2019
Q1 | $2.4M | Sell |
96,820
-9,522
| -9% | -$236K | 3.34% | 10 |
|
|
2018
Q4 | $1.91M | Buy |
106,342
+2,226
| +2% | +$40K | 2.58% | 13 |
|
|
2018
Q3 | $3.06M | Buy |
104,116
+33,618
| +48% | +$987K | 2.86% | 11 |
|
|
2018
Q2 | $3.21M | Buy |
70,498
+33,969
| +93% | +$1.54M | 2.94% | 10 |
|
|
2018
Q1 | $1.93M | Buy |
36,529
+17,012
| +87% | +$898K | 2.02% | 12 |
|
|
2017
Q4 | $1.33M | Buy |
19,517
+2,024
| +12% | +$138K | 1.36% | 20 |
|
|
2017
Q3 | $1.44M | Buy |
17,493
+6,229
| +55% | +$513K | 1.76% | 16 |
|
|
2017
Q2 | $1.06M | Buy |
+11,264
| New | +$1.06M | 1.6% | 16 |
|
|
2016
Q2 | – | Sell |
-14,666
| Closed | -$282K | – | 62 |
|
|
2016
Q1 | $282K | Buy |
+14,666
| New | +$282K | 0.54% | 25 |
|